Table 2.
Antibiotic resistance profile of Salmonella isolates from 2014 to 2018.
| Antibiotics | 2014 (n = 13) | 2015 (n = 14) | 2016 (n = 30) | 2017 (n = 18) | 2018 (n = 53) | Total (n = 128) |
|---|---|---|---|---|---|---|
| Ampicillin | 67% | 100% | 100% | 85% | 84% | 90.6% |
| Chloramphenicol | 50% | 58% | 50% | 71.4% | 57% | 62.2% |
| Ciprofloxacine | 20% | 61.5% | 33% | 50% | 68% | 52.3% |
| Doxycycline | 50% | 92% | 50% | 47% | 81% | 70.7% |
| Levofloxacine | 33% | 81% | 31% | 25% | 34% | 39.4% |
| Nalidixic acid | 100% | 100% | 81% | 64% | 89.5% | 82.5% |
| Norfloxacine | 33% | 50% | 55% | 43% | 65% | 53.2% |
| Penicillin | 100% | 100% | 100% | 67% | 100% | 94.4% |
| Tetracycline | 50% | 100% | 81% | 87% | 86.5% | 86.2% |
| Trimethoprime | 50% | 77% | 74% | 64% | 87.5% | 78.2% |
Total = total percentage of resistant strains all over five years; n = number of positive samples.